1.Prevalence and risk factors of alcohol and substance abuse among motorcycle drivers in Fars province, Iran.
Seyed Taghi HEYDARI ; Mehrdad VOSSOUGHI ; Armin AKBARZADEH ; Kamran B LANKARANI ; Yaser SARIKHANI ; Kazem JAVANMARDI ; Ali AKBARY ; Maryam AKBARI ; Mojtaba MAHMOODI ; Mohammad Khabaz SHIRAZI ; Reza TABRIZI
Chinese Journal of Traumatology 2016;19(2):79-84
PURPOSEThe aim of this present study is to investigate the prevalence of alcohol and substance abuse (ASA) and its relationship with other risky driving behaviors among motorcycle drivers.
METHODSThis is a cross sectional study which is performed at Shiraz city of Iran. Data from motorcycle drivers were collected using a standard questionnaire in eight major streets at different times of the day. The data includes consumption of alcohol and other substances two hours before driving and some of the risky behaviors during driving.
RESULTSA total of 414 drivers with a mean ± SD age of (27.0 ± 9.3) years participated in the study. Alcohol or substance consumptions two hours before driving was significantly associated with risky driving behaviors such as using mobile phone during driving, poor maneuvering, and driving over the speed limit (both p < 0.001). It was also associated with carelessness about safety such as driving with technical defects (p < 0.001) and not wearing a crash helmet (p=0.008).
CONCLUSIONScreening for alcohol and substance consumption among motorcycle drivers is an efficient way to identify drivers that are at a greater risk for road traffic accidents.
Accidents, Traffic ; mortality ; statistics & numerical data ; Adult ; Age Distribution ; Alcoholism ; complications ; epidemiology ; Chi-Square Distribution ; Confidence Intervals ; Cross-Sectional Studies ; Developing Countries ; Humans ; Iran ; Male ; Middle Aged ; Motorcycles ; statistics & numerical data ; Odds Ratio ; Prevalence ; Risk Factors ; Risk-Taking ; Substance-Related Disorders ; complications ; epidemiology ; Survival Rate ; Urban Population ; Young Adult
2.Common Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease: A Population-based Case-control Study.
Kamran B LANKARANI ; Mojtaba MAHMOODI ; Mehrzad LOTFI ; Nima ZAMIRI ; Sayed Taghi HEYDARI ; Fariborz GHAFFARPASAND ; Mohammad Kazem FALLAHZADEH ; Meisam BABAEINEJAD ; Najmeh MAHARLOUEI ; Omid MIRZAEE ; Bita GERAMIZADEH ; Payam PEYMANI
The Korean Journal of Gastroenterology 2013;62(6):344-351
BACKGROUND/AIMS: Metabolic syndrome is a well-known risk factor for atherosclerosis. Non-alcoholic fatty liver disease (NAFLD) has features of metabolic syndromes. This study aimed to investigate the association between NAFLD and atherosclerosis. METHODS: In a population-based study in southern Iran, asymptomatic adult inhabitants aged more than 20 years were selected through cluster random sampling, and were screened for the presence of fatty liver and common carotid intima-media thickness (CIMT), with abdominal and cervical ultrasonography, respectively. Those with fatty liver were compared to the same number of individuals without fatty liver. RESULTS: Two hundred and ninety individuals were found to have fatty change on abdominal ultrasonography, and were labeled NAFLD. Compared to normal individuals, NAFLD patients had significantly higher prevalence of increased CIMT (OR, 1.66; p<0.001). Those with hypertension (HTN), diabetes mellitus (DM), higher waist circumference (WC) and older ages had significantly higher prevalence of thick CIMT. Through adjusting the effects of different variables, we indicated that NAFLD could be an independent risk factor for thick common carotid intima-media (OR, 1.90; 95% CI, 1.17-3.09; p=0.009). It was also shown that age could be another independent risk factor for thick CIMT. CONCLUSIONS: Individuals with risk factors such as HTN, DM, and high WC are prone to develop atherosclerosis of the carotid artery. The presence of NAFLD should be considered as another probable independent factor contributing to the development of carotid atherosclerosis.
Abdomen/ultrasonography
;
Adult
;
Age Factors
;
Aged
;
Carotid Arteries/ultrasonography
;
*Carotid Intima-Media Thickness
;
Case-Control Studies
;
Diabetes Complications
;
Fatty Liver/epidemiology/*ultrasonography
;
Female
;
Humans
;
Hypertension/complications
;
Male
;
Middle Aged
;
Odds Ratio
;
Risk Factors
;
Waist Circumference
3.Time analysis of fatal traffic accidents in Fars Province of Iran.
Seyed-Taghi HEYDARI ; Amin HOSEINZADEH ; Yaser SARIKHANI ; Arya HEDJAZI ; Mohammad ZARENEZHAD ; Ghasem MOAFIAN ; Mohammad-Reza AGHABEIGI ; Mojtaba MAHMOODI ; Fariborz GHAFFARPASAND ; Ali RIASATI ; Payam PEYMANI ; Seyed-Mehdi AHMADI ; Kamran-B LANKARANI
Chinese Journal of Traumatology 2013;16(2):84-88
OBJECTIVETo analyze the time factor in road traffic accidents (RTAs) in Fars Province of Iran.
METHODSThis study was conducted in Fars Province, Iran from November 22, 2009 to November 21, 2011. Victims'information consisted of age, sex, death toll involving dri- vers or passengers of cars, motorcycles and pedestrians, and site of injury etc. Accidents were analyzed in relation to hour of the day, season of the year, lighting condition including sunrise, sunset, daytime and nighttime.
RESULTSA total of 3 642 deaths (78.3% were males, and the ratio of males to females was about 3.6:1) were studied regarding their autopsy records. There was a steady increase in fatal accidents occurring at midnight to 15:59. The risk of being involved in a fatal traffic accident was higher for those injured between 4:00 to 7:59 than at other times (OR equal to 2.13, 95% CI 1.85-2.44). The greatest number of fatal RTAs took place in summer. Mortalities due to RTA during spring and summer were more pronounced at 20:00 to 23:59 and midnight to 3:59, whereas mortalities in fall and winter were more pronounced from 12:00 to 15:59.
CONCLUSIONThe high mortality rate of RTA is a major public health problem in Fars Province. Our results indicate that the time is an important factor which contributes to road traffic deaths.
Accidents, Traffic ; mortality ; Adult ; Aged ; Female ; Humans ; Iran ; epidemiology ; Male ; Middle Aged ; Time Factors
4.Complementary and alternative medicine use in Iranian patients with diabetes mellitus.
Mohammad Hashem HASHEMPUR ; Mojtaba HEYDARI ; Seyed Hamdollah MOSAVAT ; Seyyed Taghi HEYDARI ; Mesbah SHAMS ; E-mail: SHAMS@SUMS.AC.IR.
Journal of Integrative Medicine 2015;13(5):319-325
OBJECTIVEThere is increasing interest in complementary and alternative medicine generally, and especially by those affected by chronic diseases, such as diabetes mellitus. We aimed to determine the prevalence and pattern of complementary and alternative medicine use among patients suffering from diabetes mellitus in Shiraz, southern Iran. Another objective was to explore associated factors for use of complementary and alternative medicine among patients with diabetes mellitus.
METHODSA 19-item semi-structured questionnaire (open- and close-ended) was administered to 239 patients with diabetes mellitus in this cross-sectional study. It was carried out in two outpatient diabetes clinics affiliated with the Shiraz University of Medical Sciences, Shiraz, Iran.
RESULTSOne hundred and eighty patients (75.3%) used at least one type of complementary and alternative medicine in the last year prior to the interview. Patients with diabetes mellitus who were living in a large family (≥5 members), not taking insulin, and believed that complementary and alternative medicine have synergistic effects with conventional medicine, were independently and significantly (P values: 0.02, 0.04, and 0.01, respectively) more likely to use complementary and alternative medicine. Most of the users (97.7%) reported use of herbal preparations, and 89.4% of users did not change their medication, neither in medication schedule nor its dosage.
CONCLUSIONThe use of complementary and alternative medicine, especially herbal remedies, is popular among diabetes patients in Shiraz, Iran. This use is associated with patients' family size, type of conventional medications and their view about concomitant use of complementary and conventional medicine.
Adult ; Aged ; Complementary Therapies ; Cross-Sectional Studies ; Diabetes Mellitus ; therapy ; Female ; Humans ; Iran ; Male ; Middle Aged ; Phytotherapy
5.Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: a double-blind placebo-controlled randomized clinical trial.
Zahra HAJMOHAMMADI ; Mojtaba HEYDARI ; Majid NIMROUZI ; Pouya FARIDI ; Mohammad Javad ZIBAEENEZHAD ; Gholamhossein Ranjbar OMRANI ; Mesbah SHAMS
Journal of Integrative Medicine 2018;16(1):45-50
BACKGROUNDLipid-lowering effect of Rhus coriaria L. (Rhus) has been investigated in multiple animal studies with promising results. Nonetheless, its clinical efficacy has not been adequately examined.
OBJECTIVEThe aim of this study was to evaluate the lipid-lowering effects of Rhus among patients with hyperlipidemia.
DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONSThe study was designed as a two-arm, double-blind placebo-controlled randomized clinical trial, using a parallel design. Eighty patients with primary hyperlipidemia were randomly assigned to receive Rhus capsules or placebo for 6 weeks.
MAIN OUTCOME MEASURESThe serum lipid levels, apolipoprotein-A1 (Apo-A1) and apolipoprotein-B (Apo-B) were measured.
RESULTSMean serum high-density lipoprotein cholesterol (HDL-C) and Apo-A1 levels were significantly increased in the Rhus group, compared with the placebo group, after 6 weeks of intervention (P = 0.001). The analysis of covariance test including age, gender, body mass index (BMI), and smoking as co-variables revealed that the increase in HDL-C and Apo-A1 levels remained significant, and increases in HDL-C were dependent on the increase in Apo-A1 levels. No significant difference was observed between Rhus and placebo groups in terms of mean reductions in total cholesterol, low-density lipoprotein cholesterol and triglyceride levels; however, more significant improvement was observed among obese patients (BMI ≥ 30 kg/m).
CONCLUSIONThe study showed significant increases in HDL-C and Apo-A1 levels in response to Rhus supplementation in patients with hyperlipidemia.
TRIAL REGISTRATIONClinicalTrials.gov ID: NCT02295293.
6.Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy.
Mohadeseh OSTOVAR ; Abolfazl AKBARI ; Mohammad Hossein ANBARDAR ; Aida IRAJI ; Mohsen SALMANPOUR ; Salar HAFEZ GHORAN ; Mojtaba HEYDARI ; Mesbah SHAMS
Journal of Integrative Medicine 2020;18(1):59-67
OBJECTIVE:
This study investigated the biochemical, histopathological and physiological effects of Citrullus colocynthis on peripheral neuropathy in rats with streptozotocin (STZ)-induced diabetes.
METHODS:
Seventy adult male Sprague-Dawley rats were included in the present study. Diabetes was induced in 60 rats, with a single intraperitoneal injection of STZ (65 mg/kg). After 4 weeks, the diabetic rats were assessed for neuropathy. Then, the diabetic rats with neuropathy were randomly divided into 6 groups for a 4-week treatment with gabapentin, oral administration of C. colocynthis fruit pulp powder (100 and 300 mg/kg per day), topical preparations as oil-based solution and ointment, or placebo. Changes in metabolic, physiological, biochemical and histological parameters were considered as treatment outcomes.
RESULTS:
Metabolic outcomes (body weight and blood glucose level) were improved in the C. colocynthis-treated groups as compared to placebo. Tail-flick and hot-plate tests also had lower latency in the C. colocynthis-treated groups. Measurement of oxidative stress markers (malondialdehyde, superoxide dismutase and catalase) showed the antioxidant effect of C. colocynthis. Histological evaluation of the sciatic nerve showed that C. colocynthis decreased the number of demyelinated and degenerated nerve fibers. Among the C. colocynthis-treated groups, the one receiving 100 mg/kg power per day orally had the best treatment outcomes.
CONCLUSION
The present study showed that C. colocynthis fruit, through its antioxidant and hypoglycemic activities, has a positive effect in the treatment of diabetic neuropathy.